Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health


Author index

Page Path
HOME > Browse Articles > Author index
Andreas J. Flammer 1 Article
The Prevalence of Cardiovascular Disease Risk Factors and the Framingham Risk Score in Patients Undergoing Percutaneous Intervention Over the Last 17 Years by Gender: Time-trend Analysis From the Mayo Clinic PCI Registry
Moo-Sik Lee, Andreas J. Flammer, Hyun-Soo Kim, Jee-Young Hong, Jing Li, Ryan J. Lennon, Amir Lerman
J Prev Med Public Health. 2014;47(4):216-229.   Published online July 31, 2014
  • 13,766 View
  • 109 Download
  • 14 Crossref
AbstractAbstract PDF
This study aims to investigate trends of cardiovascular disease (CVD) risk factor profiles over 17 years in percutaneous coronary intervention (PCI) patients at the Mayo Clinic. Methods: We performed a time-trend analysis within the Mayo Clinic PCI Registry from 1994 to 2010. Results were the incidence and prevalence of CVD risk factors as estimate by the Framingham risk score. Results: Between 1994 and 2010, 25 519 patients underwent a PCI. During the time assessed, the mean age at PCI became older, but the gender distribution did not change. A significant trend towards higher body mass index and more prevalent hypercholesterolemia, hypertension, and diabetes was found over time. The prevalence of current smokers remained unchanged. The prevalence of ever-smokers decreased among males, but increased among females. However, overall CVD risk according to the Framingham risk score (FRS) and 10-year CVD risk significantly decreased. The use of most of medications elevated from 1994 to 2010, except for β-blockers and angiotensin converting enzyme inhibitors decreased after 2007 and 2006 in both baseline and discharge, respectively. Conclusions: Most of the major risk factors improved and the FRS and 10-year CVD risk declined in this population of PCI patients. However, obesity, history of hypercholesterolemia, hypertension, diabetes, and medication use increased substantially. Improvements to blood pressure and lipid profile management because of medication use may have influenced the positive trends.


Citations to this article as recorded by  
  • Can conventional cardiovascular risk prediction models be improved by nuclear magnetic resonance (NMR) metabolomic signatures?
    Remya Sudevan
    European Journal of Preventive Cardiology.2023; 30(3): 241.     CrossRef
  • Worse outcomes of ACS patients without versus with traditional cardiovascular risk factors
    Arthur Shiyovich, Tal Ovdat, Robert Klempfner, Roy Beigel, Majdi Halabi, Avinoam Shiran, Keren Skalsky, Avital Porter, Katia Orvin, Ran Kornowski, Alon Eisen
    Journal of Cardiology.2022; 79(4): 515.     CrossRef
  • Heterogeneity of Treatment Effects for Intensive Blood Pressure Therapy by Individual Components of FRS: An Unsupervised Data-Driven Subgroup Analysis in SPRINT and ACCORD
    Yaqian Wu, Jianling Bai, Mingzhi Zhang, Fang Shao, Honggang Yi, Dongfang You, Yang Zhao
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Radial artery access is under‐utilized in women undergoing PCI despite potential benefits: Mayo Clinic PCI Registry
    Rebecca C. Chester, Syeda A. Mina, Bradley Lewis, Nan Zhang, Richard Butterfield, Eric H. Yang
    Catheterization and Cardiovascular Interventions.2020; 95(4): 675.     CrossRef
  • Temporal trends of patients with acute coronary syndrome and multi-vessel coronary artery disease - from the ACSIS registry
    Arthur Shiyovich, Nir Shlomo, Tal Cohen, Zaza Iakobishvili, Ran Kornowski, Alon Eisen
    International Journal of Cardiology.2020; 304: 8.     CrossRef
  • Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II
    Jocelyn J. Drinkwater, Timothy M. E. Davis, Valentina Hellbusch, Angus W. Turner, David G. Bruce, Wendy A. Davis
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Trends of Cardiovascular Risk Factors in Patients With Acute Myocardial Infarction: Soroka Acute Myocardial Infarction II (SAMI II) Project
    Ygal Plakht, Abeer Abu Eid, Harel Gilutz, Arthur Shiyovich
    Angiology.2019; 70(6): 530.     CrossRef
  • Sedentary lifestyle and Framingham risk scores: a population-based study in Riyadh city, Saudi Arabia
    AlJohara M. AlQuaiz, Amna Rehana Siddiqui, Ambreen Kazi, Mohammad Ali Batais, Ali M. Al-Hazmi
    BMC Cardiovascular Disorders.2019;[Epub]     CrossRef
  • Use of Global Risk Score for Cardiovascular Evaluation of Rural Workers in Southern Brazil
    Marta Regina Cezar-Vaz, Clarice Alves Bonow, Marlise Capa Verde Almeida de Mello, Daiani Modernel Xavier, Jordana Cezar Vaz, Maria Denise Schimith
    The Scientific World Journal.2018; 2018: 1.     CrossRef
  • 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
    SeyedHossein Rabani, Mahsa Sardarinia, Samaneh Akbarpour, Fereidoun Azizi, Davood Khalili, Farzad Hadaegh, Katriina Aalto-Setala
    PLOS ONE.2018; 13(5): e0195543.     CrossRef
  • Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary intervention study
    Ayman J. Hammoudeh, Imad A. Alhaddad, Yousef Khader, Ramzi Tabbalat, Eyas Al-Mousa, Akram Saleh, Mohamad Jarrah, Assem Nammas, Mahmoud Izraiq
    Journal of the Saudi Heart Association.2017; 29(3): 195.     CrossRef
  • Changing Trends of Atherosclerotic Risk Factors Among Patients With Acute Myocardial Infarction and Acute Ischemic Stroke
    Shikhar Agarwal, Karan Sud, Badal Thakkar, Venu Menon, Wael A. Jaber, Samir R. Kapadia
    The American Journal of Cardiology.2017; 119(10): 1532.     CrossRef
  • Cardiovascular manifestations of renovascular hypertension in diabetic mice
    Sonu Kashyap, Sean Engel, Mazen Osman, Yousif Al-Saiegh, Asarn Wongjarupong, Joseph P. Grande
    PeerJ.2016; 4: e1736.     CrossRef
  • Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
    Anna Franzone, Thomas Pilgrim, Dik Heg, Marco Roffi, David Tüller, André Vuilliomenet, Olivier Muller, Stéphane Cook, Daniel Weilenmann, Christoph Kaiser, Peiman Jamshidi, Lorenz Räber, Stefan Stortecky, Peter Wenaweser, Peter Jüni, Stephan Windecker
    Circulation: Cardiovascular Interventions.2015;[Epub]     CrossRef

JPMPH : Journal of Preventive Medicine and Public Health